How does Sitagliptin improve the safety profile of dual antidiabetic therapies, particularly in reducing hypoglycemia and other side effects when combined with other medications?
Sunil JoshiExplorer
How does Sitagliptin improve the safety profile of dual antidiabetic therapies?
Share
Sitagliptin, by enhancing insulin secretion only when glucose levels are elevated, lowers the risk of hypoglycemia compared to other add-ons.